PLAU and ductal breast carcinoma in situ: Using our 3D pathomimetic MAME cultures, we identified a divergent interplay between tumor-suppressive MEPs and tumor-promoting CAFs that involves PAI-1, uPA/uPAR, and IL-6 and that alters the cellular and molecular phenotype of DCIS (Fig. 8).